Internship

Regulatory Affairs

Confirmed live in the last 24 hours

Prime Medicine

Prime Medicine

201-500 employees

Biotech company focused on gene editing

No salary listed

No H1B Sponsorship

Belmont, MA, USA

We are currently not considering co-op candidates outside of the local Boston/Cambridge area.

Category
Risk & Compliance
Legal & Compliance
Required Skills
Data Analysis
Requirements
  • Currently enrolled in a Bachelor's or Master's degree program in a relevant field such as Regulatory Affairs, Life Sciences, Pharmacy, Biology, or a related discipline.
  • Strong attention to detail and organizational skills.
  • Excellent analytical, written and verbal communication skills.
  • Ability to work independently and collaboratively in a team environment.
  • Proficiency in Microsoft Office suite (Word, Excel, PowerPoint).
Responsibilities
  • Conduct research on regulatory requirements pertinent to the company's product pipeline. Stay updated on changes in regulations and guidelines affecting the industry.
  • Assist in maintaining regulatory documentation, spreadsheets, and trackers related to the compilation of required inputs for regulatory submissions. Ensure all documents and trackers are organized and up to date.
  • Support the preparation, compilation, and submission of regulatory documents to FDA and ex-US regulatory agencies. This may include applications for regulatory agency meetings, drug designations, and/or investigational new drug applications.
  • Assist in monitoring compliance of clinical-stage development programs with regulatory requirements and adherence to regulations.
  • Cross-functional collaboration with other departments, such as R&D, preclinical, and clinical teams to gather information and help ensure regulatory compliance in product development, testing, and regulatory submission packages.
  • Assist in preparing regulatory reports and responses to regulatory inquiries.
  • Participate in training sessions and educational programs to enhance understanding of regulatory requirements and processes.
  • Undertake additional ad-hoc tasks and projects as assigned by the Regulatory Affairs team to support departmental objectives and business needs.
Desired Qualifications
  • Prior experience, course work, and/or certification in regulatory affairs.
  • Familiarity with medical terminology.
  • Basic understanding of cellular and molecular biology underlying gene therapy.
  • Familiarity with document management systems and spreadsheets (Smartsheet, Excel, etc.).

Prime Medicine focuses on gene editing, specifically using a technology called Prime Editing to make precise changes to DNA. This method can identify and fix faulty DNA segments, helping to restore normal genetic function. The company aims to cure, halt, or prevent genetic diseases, providing long-term benefits to patients. Prime Medicine targets individuals with genetic disorders, a significant market globally. Unlike many competitors, it emphasizes collaboration with research institutions and pharmaceutical companies to advance its technology and bring it to market through licensing agreements and partnerships. The leadership team, including experienced professionals like Chief Technical Officer Ann L. Lee, is dedicated to enhancing the company's technological capabilities and scaling operations.

Company Size

201-500

Company Stage

IPO

Headquarters

Cambridge, Massachusetts

Founded

2019

Simplify Jobs

Simplify's Take

What believers are saying

  • Secured $244.6M to advance genetic therapies, boosting financial stability.
  • Strategic partnerships, like with Bristol Myers Squibb, offer significant growth opportunities.
  • Growing interest in gene editing for rare diseases expands market potential.

What critics are saying

  • Intellectual property disputes may lead to costly legal battles.
  • Reliance on partnerships could expose financial risks if expectations aren't met.
  • Focus on preclinical programs may delay market entry, affecting financial stability.

What makes Prime Medicine unique

  • Prime Editing offers precise DNA modifications without double-stranded breaks, unlike CRISPR.
  • Prime Medicine's partnerships with major firms like Bristol Myers Squibb enhance credibility.
  • The company's focus on lifelong benefits sets it apart in the gene editing field.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

1%

2 year growth

3%
Investing.com
Mar 19th, 2025
JMP maintains $10 target on Prime Medicine stock

Prime Medicine has been developing its Prime Editing technology, a novel genetic editing approach, which recently gained further credibility through validation by a similar method from Beam Therapeutics.

BioWorld
Mar 19th, 2025
Prime Medicine announces new α1-antitrypsin deficiency program

Prime Medicine Inc. has announced its new preclinical program for the treatment of α1-antitrypsin deficiency (AATD).

Wall Street Bolt
Dec 23rd, 2024
Prime Medicine Secures $244.6M for Therapies

Prime Medicine (PRME) has secured $244.6 million to advance its genetic therapies using its Prime Editing platform, which allows precise DNA modifications without double-stranded breaks. The company is progressing its pipeline, including therapies for chronic granulomatous disease and Wilson’s disease. A $110 million upfront payment from a partnership with Bristol Myers Squibb supports its strategic growth, with potential milestone payments exceeding $3.5 billion.

ETF Daily News
Dec 17th, 2024
Verition Fund Management LLC Makes New $149,000 Investment in Prime Medicine, Inc. (NYSE:PRME)

Verition Fund Management LLC makes new $149,000 Investment in Prime Medicine, Inc. (NYSE:PRME).

Stat News
Nov 22nd, 2024
More beef in the gene editing space

Prime Medicine plans to aggressively prosecute patent infringement.